Table 3.
Results of Framing Studies (Immunization Scenarios)
| Study | Results | Effect Modifiers | Quality Criterion |
|---|---|---|---|
| Positive Versus Negative Framing | |||
| O'Connor 199627 | No framing effect on actual immunization rates, positively framed information increased expectations of benefits of immunization and decreased expectation of incurring side effects, P < .05. | Not examined. | 1b, 2a, 3a, 3b, 5a |
| Donovan 200014 | No framing effect for intention to immunize or desire for more information when analyzed separately, favored behavior in positive frame when combined, P < .05. More favorable attitudes toward immunization in positive frame, P < .05. | Low involved respondents showed more favorable attitudes and intentions to immunize or seek information in positive frame. Analyses adjusted for age. | 2a, 3b, 5a |
| Kuhn 199718 | Vaccine described vaguely favored in negative frame. | “Vague” vaccine favored in negative frame when vagueness described verbally and low estimate (of 2 conflicting studies) presented first (P < .001), favored in positive frame when high estimate presented first. | 2a |
| Gain Versus Loss Framing | |||
| Rothman 199930 Study 1 | No framing effect. | Stratified by need for cognition—both low and high groups not influenced by framing. | 2a |
| Probability Versus Life Expectancy | |||
| Morris 200138 | More likely to favor vaccine when framed as probability, P < .01. | Those accepting vaccine willing to pay more for it when framed as life expectancy with high magnitude of benefit (age 60), P < .01. | 1a, 2a, 5a |
Quality criterion met by each study: 1a, consecutive sample; 1b, representative target group; 2a, randomized parallel group; 2b, within-subjects order of presentation randomized; 3a, attempts blinding of researchers; 3b, attempts blinding of participants; 4a, no information control group; 4b, mixed frame control group; 5a, parallel groups comparable on baseline characteristics; 5b, within-subjects baseline characteristics reported.